Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
Otavio T. Ranzani, Matt D.T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Leticia C. S. David, Rodrigo F. C. Said, Maria Almiron, View ORCID ProfileRoberto D. de Oliveira, Derek A.T. Cummings, Natalie E Dean, Jason R. Andrews, View ORCID ProfileAlbert I. Ko, Julio Croda
doi: https://doi.org/10.1101/2022.03.30.22273193
Otavio T. Ranzani
1Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra (UPF), Barcelona; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
2Pulmonary Division, Heart Institute, Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil
PhDMatt D.T. Hitchings
3Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA
SDRosana Leite de Melo
4Secretaria Extraordinária de Enfrentamento à Covid-19, Ministério da Saúde, Brasília, DF, Brazil
PhDGiovanny V. A. de França
5Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, DF, Brazil
PhDCássia de Fátima R. Fernandes
5Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, DF, Brazil
MScMargaret L Lind
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
PhDMario Sergio Scaramuzzini Torres
7Municipal Health Secretary of Manaus, AM, Brazil
Daniel Henrique Tsuha
8Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
Leticia C. S. David
9Pan American Health Organization, Brasilia, DF, Brazil
Rodrigo F. C. Said
9Pan American Health Organization, Brasilia, DF, Brazil
Maria Almiron
9Pan American Health Organization, Brasilia, DF, Brazil
PhDRoberto D. de Oliveira
8Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
10State University of Mato Grosso do Sul, Dourados, MS, Brazil
PhDDerek A.T. Cummings
11Department of Biology, University of Florida, Gainesville, FL, USA
12Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
PhDNatalie E Dean
13Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University
PhDJason R. Andrews
14Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA,USA
MDAlbert I. Ko
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
15Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil
MDJulio Croda
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
8Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
16Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 01, 2022.
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
Otavio T. Ranzani, Matt D.T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Leticia C. S. David, Rodrigo F. C. Said, Maria Almiron, Roberto D. de Oliveira, Derek A.T. Cummings, Natalie E Dean, Jason R. Andrews, Albert I. Ko, Julio Croda
medRxiv 2022.03.30.22273193; doi: https://doi.org/10.1101/2022.03.30.22273193
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
Otavio T. Ranzani, Matt D.T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Leticia C. S. David, Rodrigo F. C. Said, Maria Almiron, Roberto D. de Oliveira, Derek A.T. Cummings, Natalie E Dean, Jason R. Andrews, Albert I. Ko, Julio Croda
medRxiv 2022.03.30.22273193; doi: https://doi.org/10.1101/2022.03.30.22273193
Subject Area
Subject Areas
- Addiction Medicine (341)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2624)
- Dermatology (221)
- Emergency Medicine (397)
- Epidemiology (12169)
- Forensic Medicine (10)
- Gastroenterology (755)
- Genetic and Genomic Medicine (4061)
- Geriatric Medicine (384)
- Health Economics (675)
- Health Informatics (2620)
- Health Policy (997)
- Hematology (359)
- HIV/AIDS (843)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3829)
- Nursing (209)
- Nutrition (569)
- Oncology (2005)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6497)
- Radiology and Imaging (1388)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)